December 6, 2021International Criminal CourtOffice of the ProsecutorCommunicationsPost Office Box 195192500 CM The HagueThe NetherlandsEMAIL: otp.informationdesk@icc-cpi.intBEFORE THE INTERNATIONAL CRIMINAL COURT(TREATY OF ROME STATUTE, ART. 15.1 AND 53) Subject of complaint: - Violations of the Nuremberg Code - Violation of Article 6 of the Rome Statute - Violation of Article 7 of the Rome Statute - Violation of Article 8 of the Rome - Violation of Article 8 bis3 of the Rome Statute

'2We have tried to raise this case through the local English police and the English Court systemwithout success, we have been unable to even get the case registered either with the police orwith the court after several attempts. The statute for the ICC declares that “The ICC isintended to complement, not to replace, national criminal systems; it prosecutes cases onlywhen a State is unwilling or unable genuinely to carry out the investigation or prosecution(Article 17(1)(a)). This is such a case which is why we are addressing the ICC directly.A. BACKGROUND3The Corona virus ‘vaccines’ are an innovative medical treatment, which have only received temporary Authorisationunder Regulation 174 of the Human Medicine Regulations Act (2012). The long-term effectsand safety of the treatment in recipients are unknown. It is important to note that the CoronaVirus ‘vaccines’ are the world’s first introduction to the synthetic m-RNA technology and allprevious immunisations worked in a totally different manner, by way of introducing adeactivated or weakened virus to the body to trigger a natural arousal of the immune systemagainst it. As detailed by Dr Mike Yeadon, the risks anticipated by this innovative medicaltreatment are hereby enclosed as Appendix 1 to this request. 4All Phase 3 COVID-19 vaccine trials are ongoing and not due to conclude until late2022/early 2023. The vaccines are, therefore, currently experimental with only limited short-term and no long-term adult safety data available. In addition, they are using a completelynew mRNA vaccine technology, which has never previously been approved for use inhumans. The mRNA is effectively a pro-drug and it is not known how much spike proteinany individual will produce. Potential late-onset effects can take months or years to becomeapparent. The limited children’s trials undertaken to date are totally underpowered to rule outuncommon but severe side effects.'

Read More; https://www.docdroid.com/WUjv6iw/icc-complaint-7-1-pdf#page=3